RxDoctor Payments Data

Neil Marya, MD

Gastroenterology · Worcester, MANPI 1790046092

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $85,440 of the $126,813 with a category attached, or 67.4%. Boston Scientific accounts for 99.7% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $59,172, more than ten times the $242 reported in 2019. Among gastroenterology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$126,813in general payments, 2019–2025

Across 154 payments — averaging $823.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$126K
  • Covidien LP$242
  • Fujifilm Healthcare Americas Corporation$135
  • Medtronic$41
  • Apollo Endosurgery US Inc$13

What the payments were for

  • Consulting fees$32,85026%
  • Speaking & faculty fees$85,44067%
  • Travel & lodging$4,3303%
  • Food & beverage$4,1933%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,813 in reported general payments places this provider in the 95th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$93,398
Medicare patients
275
Services billed
573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase28$108,442
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates13$699
Omeprazole26$641
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl32$569
Ondansetron OdtOndansetron14$567
Pantoprazole Sodium16$141

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →